DK514285A - 5-cyanopyridin-2-diazohydroxid, basiske salte og fremgangsmaader til deres fremstilling og anvendelse - Google Patents
5-cyanopyridin-2-diazohydroxid, basiske salte og fremgangsmaader til deres fremstilling og anvendelse Download PDFInfo
- Publication number
- DK514285A DK514285A DK514285A DK514285A DK514285A DK 514285 A DK514285 A DK 514285A DK 514285 A DK514285 A DK 514285A DK 514285 A DK514285 A DK 514285A DK 514285 A DK514285 A DK 514285A
- Authority
- DK
- Denmark
- Prior art keywords
- diazoh
- cyanopyridine
- hydroxide
- procedures
- preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 150000001447 alkali salts Chemical class 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 230000010261 cell growth Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67020384 | 1984-11-13 | ||
| US06/670,203 US4636564A (en) | 1984-11-13 | 1984-11-13 | 5-cyanopyridine-2-diazohydroxide, basic salts and methods for production and use |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK514285D0 DK514285D0 (da) | 1985-11-07 |
| DK514285A true DK514285A (da) | 1986-05-14 |
| DK159847B DK159847B (da) | 1990-12-17 |
| DK159847C DK159847C (da) | 1991-05-13 |
Family
ID=24689433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK514285A DK159847C (da) | 1984-11-13 | 1985-11-07 | Salte af 5-cyanopyridin-2-diazohydroxid |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4636564A (da) |
| EP (1) | EP0181636B1 (da) |
| JP (1) | JPS61158967A (da) |
| AT (1) | ATE50566T1 (da) |
| AU (1) | AU576914B2 (da) |
| CA (1) | CA1255654A (da) |
| DE (1) | DE3576154D1 (da) |
| DK (1) | DK159847C (da) |
| ES (1) | ES8700238A1 (da) |
| ZA (1) | ZA858315B (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816468A (en) * | 1984-11-13 | 1989-03-28 | The University Of Alabama | 5-cyanopyridine-2-diazohydroxide, basic salts and use |
| DE4301109A1 (de) * | 1993-01-18 | 1994-07-21 | Bayer Ag | Verfahren zur Herstellung von 6-Amino-nicotinsäurenitrilen |
| ITMI20011495A1 (it) * | 2001-07-12 | 2003-01-12 | Pharmaproducts Uk Ltd | Sali di calcio ad attivita' citotossica |
| CN107602456B (zh) * | 2017-10-19 | 2021-04-06 | 北京印刷学院 | 偶氮吡啶盐化合物及制备方法 |
-
1984
- 1984-11-13 US US06/670,203 patent/US4636564A/en not_active Expired - Fee Related
-
1985
- 1985-10-29 ZA ZA858315A patent/ZA858315B/xx unknown
- 1985-11-07 DK DK514285A patent/DK159847C/da not_active IP Right Cessation
- 1985-11-12 ES ES548791A patent/ES8700238A1/es not_active Expired
- 1985-11-12 JP JP60253621A patent/JPS61158967A/ja active Granted
- 1985-11-13 AU AU49835/85A patent/AU576914B2/en not_active Ceased
- 1985-11-13 EP EP85114440A patent/EP0181636B1/en not_active Expired - Lifetime
- 1985-11-13 AT AT85114440T patent/ATE50566T1/de not_active IP Right Cessation
- 1985-11-13 CA CA000495196A patent/CA1255654A/en not_active Expired
- 1985-11-13 DE DE8585114440T patent/DE3576154D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK159847C (da) | 1991-05-13 |
| ATE50566T1 (de) | 1990-03-15 |
| EP0181636B1 (en) | 1990-02-28 |
| DK159847B (da) | 1990-12-17 |
| EP0181636A3 (en) | 1987-04-01 |
| ZA858315B (en) | 1986-10-29 |
| DK514285D0 (da) | 1985-11-07 |
| US4636564A (en) | 1987-01-13 |
| JPS61158967A (ja) | 1986-07-18 |
| DE3576154D1 (de) | 1990-04-05 |
| EP0181636A2 (en) | 1986-05-21 |
| AU576914B2 (en) | 1988-09-08 |
| ES8700238A1 (es) | 1986-10-01 |
| ES548791A0 (es) | 1986-10-01 |
| CA1255654A (en) | 1989-06-13 |
| AU4983585A (en) | 1986-05-22 |
| JPH0146511B2 (da) | 1989-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20002145B (en) | Stem Cell Factor | |
| BG60698B2 (en) | Pharmaceutical ACCEPTABLE SALTS | |
| PT81287A (en) | Process for preparing substituted propane-phosphonous acid compounds | |
| HUT49601A (en) | Process for producing piperazine derivatives and salts thereof, as well as pharmaceutical compositions comprising such piperazine deriatives and salts thereof | |
| NO883229D0 (no) | Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater. | |
| ES8601131A1 (es) | Procedimiento para produccion del compuesto (-)-trans-4-(4-fluorofenil)-3-(4-metoxifenoxi)metilpiperidina. | |
| IT8548267A0 (it) | Derivati di i,4-diidropiridina e suoi sali, procedimento per produrli e composizione farmaceutica cheli contiene | |
| SE8405588D0 (sv) | New compounds | |
| DK514285A (da) | 5-cyanopyridin-2-diazohydroxid, basiske salte og fremgangsmaader til deres fremstilling og anvendelse | |
| AP2000002017A0 (en) | Salts of paroxetine. | |
| NO932722L (no) | Salter av et 4-amino-3acyl-kinolinderivat og deres anvendelse som inhibatorer for gastrisk syresekresjon | |
| NO840526L (no) | Derivater av n-iminopyridiniumbetainer, fremgangsmaate til deres fremstilling og deres anvendelse i medikamenter | |
| DK0505400T3 (da) | N-substituerede naphthalimider, deres fremstilling og anvendelse | |
| DK524185D0 (da) | Pyrazindiazohydroxidforbindelser og fremgangsmaader til deres fremstilling og anvendelse | |
| IL77051A (en) | Crystalline form of the monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide and pharmaceutical compositions containing it | |
| MY101747A (en) | Dihydroorotic acids derivative, processes for preparing the same | |
| IL91152A0 (en) | Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| NO911508D0 (no) | Nytt s-timoloderivat og fremgangsmaate for dets fremstilling. | |
| DK0541726T3 (da) | Vækstfaktorsammensætninger, fremstilling og anvendelse | |
| ES8801624A1 (es) | Procedimiento para preparar disulfuros heterociclicos | |
| ES8601200A1 (es) | Un procedimiento para preparar compuestos de 3-(2-haloetil)-4-oxopirazolo-(5, 1-d)-1, 2, 3, 5-tetrazin-8-carboxamida | |
| ES8605261A1 (es) | Un procedimiento para la preparacion de 1,4-aminoalquilamino-9-h-tioxaten-9-onas. | |
| DK0580644T3 (da) | 1,3,4-trisubstituerede piperidin-derivater, fremstilling og anvendelse heraf | |
| MY102682A (en) | Substituted pyridinesulfonamide compounds, herbicidal composition containing them, and method of preparing these compounds | |
| DK0463139T3 (da) | 2,13-disubstituerede ergoliner, deres fremstilling og deres anvendelse i lægemidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |